AI-Powered Signal Detection in Pharmacovigilance

Last updated: 16.7.2025
Grant

The AI-Powered Signal Detection in Pharmacovigilance topic, part of the Innovative Health Initiative JU Call 11 under Horizon Europe, aims to revolutionize drug safety by leveraging artificial intelligence. This program supports the development and implementation of advanced AI algorithms and methods for faster and more accurate signal detection and risk prediction in pharmacovigilance, ultimately enhancing patient safety across Europe.

Who is Funded

This section provides an overview of who is generally eligible for funding under the AI-Powered Signal Detection in Pharmacovigilance program. It details the specific types of entities, the geographical scope, and the overarching objectives that define the intended beneficiaries and strategic aims of the program.

What is Funded

This section details the types of projects, thematic areas, and activities eligible for funding, focusing on the specific applications of AI in pharmacovigilance. It clarifies the scope of work supported and the typical developmental stage of the projects.

Type and Scope of Funding

This section provides comprehensive details on the nature and extent of financial support available, including the type of financial instrument used and the maximum funding amount per project.

Conditions and Requirements

This section outlines the essential rules, regulations, and specific conditions that applicants and beneficiaries must adhere to. It covers application terms, collaboration requirements, budget stipulations, and other important provisions for projects.

Application Procedure

This section guides potential applicants through the various stages of the application procedure for the AI-Powered Signal Detection in Pharmacovigilance program. It covers proposal preparation, submission, required documentation, and explains how applications are evaluated.

This section outlines the foundational legal documents and regulations that govern the AI-Powered Signal Detection in Pharmacovigilance funding program, ensuring its legitimacy and operational framework.

Similar Programs

#AI-Powered Pharmacovigilance#Signal Detection#Patient Safety#Horizon Europe#Innovative Health Initiative#Risk Prediction#Regulatory Compliance#Health Data Space#Machine Learning#Research Grants#Drug Safety#Clinical Studies#Health Technology#Data Analytics#Ethical AI#Consortium Funding

Funding Overview

Funding Status

Funding Status:

Open

Maximum Amount

Maximum Amount:

8,906,000 €

Allocated Budget

Allocated Budget:

8,906,000 €

Deadline

Deadline:

09.10.2025, 29.04.2026

Award Channel

Award Channel:

Framework Programme Call

Region

Region:

EU Member States and Horizon Europe Associated Countries (excluding UK and Canada)

Sectors

Sectors:

Healthcare, Research and Development, Information and Communication Technology, Medical Technology

Application Type

Application Type:

Consortium Required

Funding Stages

Funding Stages:

Applied Research, Experimental Development, Prototyping, Pilot Testing, Product Development, Process Optimization, Market Introduction

Funding Provider

Program Level:

European Union

Funding Body:

European Commission

Managed By:

Innovative Health Initiative Joint Undertaking (IHI JU)

0 x 0
XS